Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3144 results

Sort By:

Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negative Breast Cancer)

Study ID: NCT07255612
Start Date: 2026-11-04
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

29

Intervention / Treatment

Trilaciclib

Eribuli

Sponsor

Sun Yat-sen University

Source: clinicaltrials.gov

Share:
Add to list

Treatment of Skeletal Class II Malocclusion With Modified Twin-Block Appliance With Clear Plates

Study ID: NCT05950581
Start Date: 2026-03-15
End Date: 2026-09-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

32

Intervention / Treatment

Modified Twin-Block Appliance with Clear Plates.

Traditional Twin-Block appliance

Sponsor

Hama University

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

Study ID: NCT07434609
Start Date: 2027-12-01
End Date: 2030-12-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

150

Intervention / Treatment

T320 for Injection

Sponsor

Nanolattix Biotechnology Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II

Study ID: NCT07131722
Start Date: 2026-07
End Date: 2028-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Trineumin

Trineumin

Trineumin

Sponsor

PRG Science & Technology Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Enhanced Ward Rounds for Bowel Preparation Quality in Hospitalized Patients Undergoing Colonoscopy

Study ID: NCT07263867
Start Date: 2026-03-28
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Enhanced Frequency Ward Rounds with Standardized Intervention Package

Standard Frequency Ward Rounds

Sponsor

LanZhou University

Source: clinicaltrials.gov

Share:
Add to list

Digital Tools to Engage and Activate Patients During Hospitalization

Study ID: NCT06973707
Start Date: 2028-07-01
End Date: 2030-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

520

Intervention / Treatment

Passive Digital Tools

Active Digital Tools

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers

Study ID: NCT03166072
Start Date: 2026-04-20
End Date: 2027-12-20
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Meditation

Health Enhancement Program

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Source: clinicaltrials.gov

Share:
Add to list

Sarcopenia in Chronic Kidney Disease (CKD) Patients

Study ID: NCT07437053
Start Date: 2026-06-01
End Date: 2027-10-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

20

Intervention / Treatment

Valine

EEA

Sponsor

The University of Texas Health Science Center at San Antonio

Source: clinicaltrials.gov

Share:
Add to list

MUSCLE-ML: Multimodal Integration of Muscle Strength, Structure by Machine Learning for Precision Rehabilitation After ACL Injury

Study ID: NCT07284771
Start Date: 2026-04-01
End Date: 2028-08-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

182

Intervention / Treatment

No Intervention: Observational Cohort

Sponsor

Chinese University of Hong Kong

Source: clinicaltrials.gov

Share:
Add to list

Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma

Study ID: NCT07181941
Start Date: 2026-04-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Linvoseltamab

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Positron Emission Tomography

Biospecimen Collection

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list